Relmada Therapeutics, Inc. - RLMD

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Pharmaceutical Preparations
Latest data: 9/14/2026 10:02:20 PM
EDGAR CIK 0001553643

Buy Breakdown

Total $4,030,050

Sell Breakdown

Total $0

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
09/10/2026
09/11/2026
Shenouda Maged
Chief Financial Officer
CFO
Buy
79,800 @ $4.25
$339,150.00
 1,000,000 (8.67%) Direct
09/10/2026
09/11/2026
Traversa Sergio
Chief Executive Officer
CEO Director
Buy
100,000 @ $4.10
$410,000.00
 1,500,000 (7.14%) Direct
09/09/2026
09/11/2026
Shenouda Maged
Chief Financial Officer
CFO
Buy
120,200 @ $4.20
$504,840.00
 920,200 (15.02%) Direct
09/09/2026
09/11/2026
Traversa Sergio
Chief Executive Officer
CEO Director
Buy
100,000 @ $4.18
$418,000.00
 1,400,000 (7.69%) Direct
12/15/2025
12/16/2025
Shenouda Maged
Chief Financial Officer
CFO
Buy
11,665 @ $4.12
$48,059.80
 800,000 (1.48%) Direct
12/15/2025
12/16/2025
Traversa Sergio
Chief Executive Officer
CEO Director
Buy
27,500 @ $4.12
$113,300.00
 1,300,000 (2.16%) Direct
11/05/2025
11/06/2025
Ence Chuck
CAO and COO
Officer
Buy
136,000 @ $2.20
$299,200.00
 403,931 (50.76%) Direct
11/05/2025
11/06/2025
Kelly Paul Edward
Chief Operating Officer
Officer Director
Buy
90,000 @ $2.20
$198,000.00
 502,295 (21.83%) Direct
11/05/2025
11/06/2025
Shenouda Maged
Chief Financial Officer
CFO
Buy
500,000 @ $2.20
$1,100,000.00
 788,335 (173.41%) Direct
11/05/2025
11/06/2025
Traversa Sergio
Chief Executive Officer
CEO Director
Buy
272,500 @ $2.20
$599,500.00
 1,272,500 (27.25%) Direct